LIBROS
Seifer DB, Kennard EA, ed.Menopause: Endocrinology and management. Totowa: Humana Press,1999.
Fraser IS, Jansen PSR, Lobo RA,Whitehead MI, eds. Estrogens and progestagens in clinical practice.New York: Churchill Livingstone, 1999.
Rosenfeld RG, Roberts C, eds.The IGF system: Molecular biology, physiology and clinicalapplications. Totowa: Humana Press, 1999.
Kozlowski K, Beighton P, eds.Gamut index of skeletal dysplasias: an aid to radiodiagnosis(3.a ed.). London: Springer, 1999.
NÚMEROSMONOGRÁFICOS
Manuscritos del 9th EuropeanMeeting on Injectable Bone and Joint Substitution Materials. Bone1999; 25 (Supl 2): 1S-112S.
Luque M, Rapado A, eds.Hipertensión y osteoporosis. Madrid: Idepsa,1999.
NUESTROSAUTORES
Bernard M, Jaramillo G, AguadoP, et al. Polimorfismo del gen del receptor de la vitamina D ydensitometría ósea en mujerespostmenopáusicas. Med Clin (Barc) 1999; 112:651-655.
Honorato J, Escolar M,García E. Relaciones hipertensión arterialesencial-osteoporosis: impacto del tratamiento antihipertensivosobre el metabolismo extracelular del calcio. Rev Clin Esp 1999;199: 523-529.
Carballo PJ, Gabriel SE, CastroMR. Changes in bone density after exposure to oral anticoagulants:A meta analysis. Osteoporosis Int 1999; 9: 441-448.
Castro MDL, FernándezRomero JM, Ortiz Boyer B. Determination of vitamin D3 metabolites:state-of-the-art and trends. J Pharm Biomed Anal 1999; 20:1-17.
Se ruega a los autoresenviar una copia del trabajo para incluir su cita en estasección.
REVISIONES
Roshan S, Nader S, Orander P.Ageing and hormones. Eur J Clin Invest 1999; 29:210-213.
Keski-Oja. Vitamin D3derivatives (deltanoids) in the treatment of tumor cell invasion. JLab Clin Med 1999; 133: 95-97.
Guyatt GH. Evidence-basedmanagement of patients with osteoporosis. J Clin Densitometry 1999;1: 395-402.
Spelsberg TC, Subramanian M,Riggs BL. The actions and interactions of sex steroids and growthfactors/cytokines on the skeleton. Mol Endocrinol 1999; 13:819-828.
De Luca F, Baron J. Control ofbone growth by fibroblast growth factors. Trends Endocrinol Metab1999; 10: 61-65.
Cosman F, Lindsay R. Selectiveestrogen receptor modulators: clinical spectrum. Endocr Rev 1999;20: 418-434.
Nemeth EF, Fox J. Calcimimeticcompounds: a direct approach to controlling plasma levels ofparathyroid hormone in hyperparathyroidism. Trends Endocrinol Metab1999; 10: 66-71.
Rae SA, Wang WJ, Partridge D.Artificial neural networks: a potential role in osteoporosis. JRSoc Med 1999; 92: 119-122.
Pal B. Questionnaire survey ofadvice given to patients with fractures. BMJ 1999; 318:500-501.
Francis RM. The effects oftestosterone on osteoporosis in men. Clin Endocrinol (Oxf) 1999;50: 411-414.
Boyce BF, Hughes DE, Wrigh KR,et al. Recent advances in bone biology provide insight into thepathogenesis of bone diseases. Lab Invest 1999; 79:83-94.
Hofbauer LC, Khosla S. Androgeneffects on bone metabolism: recent progress and controversies. EurJ Endocrinol 1999; 140: 271-286.
Homik JE, Granney A, Shea B,Tugwell P. A metaanalysis on the use of biphosphonates incorticosteroid induced osteoporosis. J Rheumatol 1999; 26:1.148-1.157.
Whyte MP, Eddy MC, PodgornikMN, McAlister WH. Polycystic bone disease: a new autosomal dominantdisorder. J Bone Miner Res 1999; 14: 1.261-1.271.
Bishop N. Rickets today Children still need milk and sunshine. N Engl J Med 1999; 341:602-604.
Chapurlat R, Meunier PJ. Thenonsurgical treatment of fibrous dysplasia. Rev Rhumat 1999; 66:1-3.
Pereira SP, Bray GP, Pitt PI,et al. Non-invasive assessment of bone density in primary biliarycirrhosis. Eur J Gastroenterol Hepatol 1999; 11:323-328.
Hofbauer LC, Khosla S.Androgens effects on bone metabolism: recent progress andcontroversies. Eur J Endocrinol 1999; 140: 271-286.
Rosenbloom AL, MartínezV, Kranzier JH, et al. Natural history of growth hormone receptordeficiency. Acta Paediatr Suppl 1999; 88: 153-156.
Frost HM. On the estrogen-bonerelationship and postmenopausal bone loss: a new model. J BoneMiner Res 1999; 14: 1.473-1.477.
Levine MA.Pseudohypoparathyroidism: from bedside to bench and back. J BoneMiner Res 1999; 14: 1.255-1.260.
Bauer DC, Slarin PM, Stone KL,et al. Biochemical markers of bone turnover and prediction of hipbone loss in older women: the study of osteoporotic fractures. JBone Miner Res 1999; 14: 1.404-1.410.
Zmuda JM, Cauley JA, FerrellRE. Recent progress in understanding the genetic susceptibility toosteoporosis. Genet Epidemiol 1999; 16: 356-367.
Pollard JW. Genetic regulationof estrogen responsiveness. Endocrinology 1999; 140:553-555.
Shoemaker LR. Expanding role ofbiphosphonate therapy in children. J Pediatr 1999; 134:264-267.
Bhatia M, Bonner D, Wu D. Bonemorphogenetic protein regulate the developmental program of humanhematopoietic stem cells. J Exp Med 1999; 189:1.139-1.147.
Steel N.Dehydro-epiandrosterone and ageing. Age Ageing 1999; 28:89-91.
Crawford-Sharpe G, Rosen CJ.Insulin-like growth factor-I and the skeleton: new perspectives.Endocrinologist 1999; 9: 81-86.
Aubin JE, Candeliere GA,Bonnelye E. The heterogeneity of the osteoblast phenotype.Endocrinologist 1999; 9: 25-31.
Ducy P, Karsenty G.Transcriptional control of osteoblast differentiation.Endocrinologist 1999; 9: 32-35.
Croarkin E. Osteopenia in thepatient with cancer. Phys Ther 1999; 79: 196-201.
Lipworth BJ. Systemic adverseeffects of inhaled corticosteroid therapy. A systematic review andmeta-analysis. Arch Intern Med 1999; 159: 941-945.
Burger EH, Klein-Nulend J.Mechanotransduction in bone role of the lacunocanalicularnetwork. FASEB J 1999; S101-112.
OTROS ARTÍCULOSDE INTERÉS
Michaelsson K, Baron JA,Farahmand Y. Oral-contraceptive use and risk of hip fracture: acase control study. Lancet 1999; 353: 1.484-1.488.
Hadji P, Hars O, Wuster C, etal. Stiffness index identifies patients with osteoporotic fracturesbetter than ultrasound velocity or attenuation alone. Maturitas1999; 31: 221-226.
Center JR, Nguyen TV, SchneiderD. Mortality after all major types of osteoporotic fracture in menand women: an observational study. Lancet 1999; 353:878-882.
Cornuz J, Feskanich D, WilletWC. Smoking, smoking cesation, and risk of hip fracture in women.Am J Med 1999; 106: 311-314.
Goulding A, Taylor RW, Keil D,Gold E. Lactose malabsorption and rate of bone loss in older women.Age Ageing 1999; 28: 175-180.
Bischoff H, Stahelin HB, VogtP. Immobility as a major cause of bone remodeling in residents of along-stay geriatric ward. Calcif Tissue Int 1999; 64:485-489.
Stewart A, Porter RW, PrimroseWR, et al. Cervical and trochanteric hip fractures: Bone mass andother parameters. Clin Rheumatol 1999; 18: 201-206.
Gangji V, Apopelboom T.Analgesic effect of intravenous pamidronate on chronic back paindue to osteoporotic vertebral fractures. Clin Rheumatol 1999; 18:266-267.
Forsen L, Meyer HE, MidthjellK, Edna TH. Diabetes mellitus and the incidence of hip fracture.Results from the Nord-Trondelag Healh Survey. Diabetologia 1999;42: 920-925.
Savage MO, Beattie RM, CamachoC, et al. Growth in Crohn's disease. Acta Paediatr 1999; (Suppl428): 89-92.
Kado BM, Browner WS, Palermo L,et al. Vertebral fractures and mortality in older women. Aprospective study. Arch Int Med 1999; 159: 1.215-1.220.
Crosbie OM, Freaney R, McKennaMJ, Hegarty JE. Bone density, vitamin D status, and disordered boneremodeling in end-stage chronic liver disease. Calcif Tissue Int1999; 64: 295-300.
Gordon CM, Grace E, Jean EmansS, et al. Changes in bone turnover markers and menstrual functionafter short-term oral DHEA in young women with anorexia nervosa. JBone Miner Res 1999; 14: 136-145.
Selby PL, Davies M, Adams JE,Mawer EB. Bone loss in celiac disease is related to secondaryhyperparathyroidism. J Bone Miner Res 1999; 14: 652-657.
Mora S, Barera G, Beccio S, etal. Bone density and bone metabolism are normal after long-termgluten-free diet in young celiac patients. Am J Gastroenterol 1999;94: 398-403.
Greenspoon S, Miller K, CoyleC, et al. Severity of osteopenia in estrogen-deficient women withanorexia nervosa and hypothalamic amenorrhea. J Clin EndocrinolMetab 1999; 84: 2.049-2.055.
Isaia GC, Ardissone P, DiStefano M, et al. Bone metabolism in type 2 diabetes mellitus. ActaDiabetologica 1999; 36: 35-38.
Shaarawy M, El-Dawakhly AS,Mosaad M, El-Sadek MM. Biomarkers of bone turnover and bone mineraldensity in hyperprolactinemic amenorrheic women. Clin Chem Lab Med1999; 37: 433-438.
Boyde A, Travers R, GlorieuxFH, Jones SJ. The mineralization density of iliac crest bone fromchildren with osteogenesis imperfecta. Calcif Tissue Int 1999; 64:185-190.
Katigiri H, Takahashi M,Inagaki J, et al. Determining the site of the primary cancer inpatients with skeletal metastasis of unknown origin: aretrospective study. Cancer 1999; 86: 533-537.
Lo Cascio V, Bertoldo F,Gambaro G, et al. Urinary galactosyl-hydroxylisine inpostmenopausal osteoporotic women: a potential marker of bonefragility. Bone Miner Res 1999; 14: 1.420-1.424.
Christiansen P, Steiniche T,Brixen K, et al. Primary hyperparathyroidism: Short-term changes inbone remodeling and bone mineral density followingparathyroidectomy. Bone 1999; 25: 237-244.
Kannus P, Parkkari J, PoutalaJ. Comparison of force attenuation properties of four different hipprotectors under simulated falling conditions in the elderly: an invitro biomechanical study. Bone 1999; 25: 229-236.
Edmondston SJ, Price RI,Valente B, Singer KP. Measurement of vertebral body heights:ex-vivo comparisons between morphometric X-ray absorptiometry,morphometric radiography and direct measurements. Osteoporosis Int1999; 10: 7-13.
Pluskiewicz W, Drozdzowska B.Ultrasound measurements at the calcaneus in men: differencesbetween healthy and fractured persons and the influence of age andanthropometric features on ultrasound parameters. Osteoporosis Int1999; 10: 47-51.
De Laet CDEH, van Houl BA,Burger H, et al. Incremental cost of medical care after hipfracture and first vertebral fracture: the Rotterdam Study.Osteoporosis Int 1999; 10: 66-72.
Hampl H, Steinmuller T,Frohling P, et al. Long-term results of total parathyroidectomywithout autotransplantation in patients with and without renalfailure. Mineral Electrol Metab 1999; 25: 161-170.